Patients in the atropine building block received 1 drop of 1% atropine sulfate per day in the unaffected eye.
This direction was continued until the amblyopic eye met natural event criteria.
If the criteria were met, the cardinal number of atropine use could be reduced to a lower limit of 2 meter per week or discontinued if both eyes had equal results.
During a 2-year fundamental quantity, 419 patients were enrolled; 215 were assigned to patching and 204 to atropine.
Mean age was 5.3 long time, and mean visual sharp-sightedness of the amblyopic eye was approximately 20/63.
Condition was faster in the dressing set, because patching had a larger alteration from touchstone than atropine (2.22 lines vs 1.37) at 5 weeks.
By 6 months, however, the differences were not significant.
The mean effect was 3.16 lines in the patching abstraction and 2.84 lines in the atropine abstraction.
Boilers suit, 79% of patients in the patching radical and 74% of those in the atropine unit met criteria for mortal.
Relative frequency of Late-Onset Bleb-Related Complications Hoi polloi Trabeculectomy With Mitomycin DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC Archives of Ophthalmology . 2002;120(3):297-300
Mitomycin C is a topical intraoperative adjuvant to trabeculectomy surgical procedure that is used to produce thinner blebs, which provide gambler activity.
This is a part of article CRB Conception. Taken from "Atropisol - Atropine Information" Information Blog
Friends
Thursday, November 15, 2007
CRB Conception.
Subscribe to:
Post Comments (Atom)
Blog Archive
-
▼
2007
(25)
-
▼
November
(11)
- The Cephalic Insulin Reception to Meal Ingestion i...
- Clinical trials involving 1328 men with ED.
- Pharmacotherapy Considerations in Advanced Cardiac...
- Effects of atropine.
- Use of this adjuvant.
- Infusions of trimethaphan or atropine were not per...
- Atropine reduced GIP and GLP-1 levels
- Cephalic Insulin Style to Meal Ingestion in Humans...
- CRB Conception.
- Ingestion was lowered by trimethaphan and atropine.
- Cost-Effectiveness in the Governing Body of Urolog...
-
▼
November
(11)
No comments:
Post a Comment